Novo Nordisk A/S

Novo Nordisk A/S

NVO · NYSE
NVO · NYSE
37.82
USD-1.09-2.81%

Data

Tickery

Nagłówek

Źródło

    *NOVO NORDISK STARTS MULTI-MONTH SUBSCRIPTION PROGRAM FOR WEGOVY $NVO https://t.co/mM14BZXQB3

    Investingcom
    @Investingcom

      *NOVO AND HIMS END FEUD, WILL SELL OBESITY DRUGS TOGETHER $NVO $HIMS https://t.co/RvbLhOWfuZ

      Investingcom
      @Investingcom

        *NOVO NORDISK TO CUT OZEMPIC, WEGOVY'S US LIST PRICES BY UP TO 50%: WSJ $NVO https://t.co/fBJ05M6MNr

        Investingcom
        @Investingcom

          STARTS NOW! Rebel's Edge 1pm 🕐 $VNDA $ACLX $NVO $DPZ 🏈 NAJARIAN SPORTS 🏴‍☠️ with @petenajarian Winter Olympics: Hockey Finals was scripted perfectly, but did it reach 1980 levels? NFL: Chicago Bears, will they need to change the team's name? Indiana looking to build a Dome, NW https://t.co/CUnDFsQQz7

          MarketRebels
          @MarketRebels

            *NOVO NORDISK SINKS 15% AFTER WEIGHT LOSS DRUG FAILS TO MATCH ELI LILLY'S IN TRIAL $NVO $LLY https://t.co/xRsnosJ0yS

            Investingcom
            @Investingcom

              4 stocks to watch on Monday: LLY, NVO, APO, TTE

              SeekingAlpha

                *NOVO NORDISK SHARES SINK AFTER SALES OUTLOOK MISSES FORECAST $NVO https://t.co/NYcHbsSOue

                Investingcom
                @Investingcom

                  📅IT’S A BIG WEEK OF EARNINGS! 📈 $GOOGL $AMZN $AMD $PLTR $QCOM $ARM $SMCI $RDDT $RBLX $SNAP $PYPL $AFRM $UBER $DIS $PEP $CMG $TSN $LLY $NVO $PFE $MRK $COP $SHEL $B WILL DELIVER RESULTS! 💰MAKE SMARTER INVESTMENT DECISIONS WITH ‘PRO PICKS AI’: 🎁GET 50% OFF ALL PRO PLANS FOR https://t.co/hCLP39WM0n

                  Investingcom
                  @Investingcom

                    4 stocks to watch on Monday: NVO, PANW, OKTA, TWLO

                    SeekingAlpha

                      *NOVO NORDISK EXTENDS GAIN TO 10% AS WEGOVY PILL APPROVED IN US $NVO https://t.co/HTqEikpfvR

                      Investingcom
                      @Investingcom

                        *NOVO NORDISK SHARES PLUNGE 10% AFTER ALZHEIMER’S DRUG TRIAL FAILS TO HIT KEY TARGET $NVO https://t.co/TRBNffy1K5

                        Investingcom
                        @Investingcom

                          STARTS NOW! Rebel's Edge 🏴‍☠️ 1pm Stocks $DAY $NVO $WULF $EQT 🏈NAJARIAN SPORTS with @petenajarian Best Week 1, 2, 3 of College Football Biggest schools playing each other Heisman way to early read: I have a dark horse, but Arch is sitting at the top https://t.co/j2t4k86P3o

                          MarketRebels
                          @MarketRebels

                            *NOVO NORDISK SHARES PLUNGE 20% AFTER CUTTING FULL-YEAR GUIDANCE, NAMING NEW CEO $NVO https://t.co/xg8Nvsv4mD

                            Investingcom
                            @Investingcom

                              *NOVO NORDISK CEO TO STEP DOWN IN A SURPRISE MOVE $NVO https://t.co/JVN0yjXC6c

                              Investingcom
                              @Investingcom

                                Premarket Mover: $CVS +8% ✅ Q1 beats on top & bottom line 🛑 Exiting individual ACA insurance (#Obamacare) 🤝 Teams up with $NVO to boost access to weight-loss drug #Wegovy https://t.co/i9HgDC7DhN

                                SeekingAlpha
                                @SeekingAlpha

                                  Shares of Hims & Hers Health $HIMS are up double digits after the telehealth company announced a partnership with Novo Nordisk $NVO to sell the Danish drugmaker’s popular weight loss therapy, Wegovy. #Wegovy #WeightLoss #Healthcare #MarketWatch https://t.co/P3l230QDgw

                                  SeekingAlpha
                                  @SeekingAlpha

                                    *NOVO NORDISK’S DIABETES PILL SLASHES RISK OF CARDIOVASCULAR COMPLICATIONS BY 14% AFTER FOUR YEARS $NVO https://t.co/aUPHWSp1f5

                                    Investingcom
                                    @Investingcom

                                      Novo Nordisk reported full-year revenue of $40.5B, up 25% compared to 2023 Wednesday. For Q4 $NVO reported $11.6B in revenues, up 30% compared to the same quarter in 2023. The company's blockbuster semaglutide drugs, Wegovy for weight loss and Ozempic for diabetes, were key… https://t.co/lTuClsWXaK https://t.co/7h4Uvwelz2

                                      YahooFinance
                                      @YahooFinance

                                        ⚠️ JUST IN: *NOVO NORDISK BEATS EARNINGS ESTIMATE AS WEGOVY WEIGHT LOSS DRUG SALES JUMP 107% IN Q4 $NVO +3.6% https://t.co/vtyL7vyC4H

                                        Investingcom
                                        @Investingcom

                                          🎉ANOTHER BIG EARNINGS WEEK IS UPON US! 💰 $GOOGL $AMZN $AMD $ARM $QCOM $PLTR $SNAP $DIS $PYPL $LLY $PFE $MRK $NVO $UBER $F $RACE $TM $PEP $CMG ARE ALL SET TO DELIVER RESULTS! 📈PLAN EARLY WITH ALL KEY DATA IN 1 PLACE: https://t.co/Zh3sZIRv6K 👈 https://t.co/0Zont0zt9H https://t.co/JTwOtijLxx

                                          Investingcom
                                          @Investingcom

                                            "Denmark stock market -20% since Sept 24 driven by Novo Nordisk -40%... NVO was 60% of stock market; best reminder of concentration risk" - BofA's Hartnett https://t.co/QMb8bJr6A4

                                            zerohedge
                                            @zerohedge

                                              ⚠️BREAKING: *NOVO NORDISK STOCK PLUNGES 16% AFTER WEIGHT-LOSS DRUG DATA DISAPPOINTS; RIVAL ELI LILLY JUMPS 5% $NVO $LLY https://t.co/3v081kCR1V

                                              Investingcom
                                              @Investingcom

                                                STARTS NOW! Rebel's Edge 🏴‍☠️1pm line up: Fed speak 🗣️ and ongoing inflation concerns. $NVO $PARA $TSLA $ARDX Sports @petenajarian 🏈 #NFL Sleeper team for NFC Atlanta, if Cousins is healthy, that offense will roll https://t.co/W9YiylSHZi

                                                MarketRebels
                                                @MarketRebels

                                                  ⚠️ JUST IN: *NOVO NORDISK SHARES JUMP 4% TO HIT NEW RECORD HIGH AS  WEGOVY GETS APPROVAL IN CHINA ARE YOU BUYING OR SELLING? $NVO https://t.co/n5ugypCcym

                                                  Investingcom
                                                  @Investingcom

                                                    ⚠️ JUST IN: *NOVO NORDISK TOPS EARNINGS ESTIMATE, RAISES OUTLOOK FUELLED BY SOARING OBESITY DRUG DEMAND $NVO https://t.co/h8x2y31Zhg

                                                    Investingcom
                                                    @Investingcom

                                                      ⚠️BREAKING: *NOVO NORDISK STOCK SOARS TO A NEW RECORD AS IT TOUTS THE POTENTIAL OF ITS NEXT-GEN OBESITY TREATMENTS $NVO https://t.co/wHxSn00a1w

                                                      Investingcom
                                                      @Investingcom

                                                        ⚠️ JUST IN: *NOVO NORDISK, THE OBESITY DRUG MAKER, BECOMES THE SECOND-EVER EUROPEAN COMPANY TO REACH A $500 BILLION MARKET VALUE $NVO https://t.co/AzkbwhSOP7

                                                        Investingcom
                                                        @Investingcom

                                                          ⚠️BREAKING: *NOVO NORDISK’S WEIGHT LOSS DRUG WEGOVY SLASHES RISK OF SERIOUS HEART EVENTS, INCLUDING HEART ATTACK AND STROKE $NVO https://t.co/zpTx6CWWar

                                                          Investingcom
                                                          @Investingcom

                                                            #earnings before the open tomorrow https://t.co/lObOE0dgsr $MRNA $RCL $DDOG $BUD $PTON $W $NVO $COP $PARA $SHEL $PLNT $K $RACE $REGN $PENN $CG $CAH $H $ATI $AUYTL $LNTH $PZZA $ARGX $ZTS $DINO $SHAK $AUPH $BHC $STWD $TGLS $BWA $PCG $SWK $FOUR $AG $PRVA $AEP $NFE $EQNR $PH $CMRX… https://t.co/ZdNHGu9zTe

                                                            eWhispers
                                                            @eWhispers

                                                            FAQ

                                                            Jaka jest cena akcji Novo Nordisk A/S dzisiaj?

                                                            Jaki jest symbol giełdowy akcji Novo Nordisk A/S?

                                                            Czy cena akcji NVO rośnie?

                                                            Jakie jest zalecenie analityków dla NVO?

                                                            Jaka jest kapitalizacja rynkowa NVO?

                                                            Czy NVO publikuje raporty finansowe?

                                                            Kiedy jest kolejna data raportu finansowego NVO?

                                                            Jakie były zyski NVO za ostatni kwartał?

                                                            Jakie były przychody NVO za ostatni kwartał?

                                                            Jakie były dochody netto NVO za ostatni kwartał?

                                                            Czy NVO wypłaca dywidendy?

                                                            Ile osób zatrudnia NVO?

                                                            Czym jest EBITDA NVO?

                                                            Jak kupić akcje NVO?

                                                            Czy powinienem inwestować w akcje NVO?